Comprehensive medication guide to Imitrex including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$15 copay for generic sumatriptan; Tier 1–2 on most commercial and Medicare plans. Some plans require prior authorization or have quantity limits of 9 tablets per 30 days.
Estimated Cash Pricing
$15–$88 retail for generic sumatriptan; as low as $10.40 with GoodRx or SingleCare coupons for a 9-tablet supply. Brand-name Imitrex costs $138–$300+ without insurance.
Medfinder Findability Score
88/100
On this page
Imitrex is the brand name for sumatriptan succinate, a prescription migraine medication first approved by the FDA in 1992. It was the first triptan ever brought to market and remains one of the most widely prescribed acute migraine treatments in the United States. Generic versions of sumatriptan have been available since 2008 when the original patent expired, making it one of the most affordable migraine medications available today.
Imitrex belongs to the drug class known as triptans — selective serotonin (5-HT1B/1D) receptor agonists. It is FDA-approved for the acute treatment of migraine headaches with or without aura in adults. The injection form is also approved for cluster headaches. It is available as oral tablets (25 mg, 50 mg, 100 mg), nasal spray (5 mg, 10 mg, 20 mg), and subcutaneous injection (4 mg and 6 mg).
Imitrex is an acute (abortive) treatment — it stops a migraine in progress. It does NOT prevent future migraines. It is not appropriate for everyday headache or tension headache. Other brand names for sumatriptan include Tosymra (nasal spray), Onzetra Xsail (breath-powered intranasal powder), Zembrace SymTouch (injection auto-injector), and Treximet (sumatriptan combined with naproxen sodium).
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Sumatriptan works through a dual mechanism targeting the two main drivers of migraine pain. It binds to and activates 5-HT1B receptors on the smooth muscle walls of intracranial blood vessels, causing vasoconstriction — narrowing the dilated blood vessels around the brain that contribute to the throbbing migraine pain. Simultaneously, it activates 5-HT1D receptors on trigeminal nerve endings, inhibiting the release of calcitonin gene-related peptide (CGRP) and other inflammatory neuropeptides that drive neurogenic inflammation during a migraine attack.
This dual action — vasoconstriction and neuroinhibition — is what makes triptans uniquely effective for migraines compared to general pain relievers like ibuprofen or acetaminophen, which do not target these specific migraine mechanisms. Sumatriptan is most effective when taken at the earliest sign of a migraine; once central sensitization (overactivation of spinal cord pain centers) sets in, the drug becomes less effective.
The oral bioavailability of sumatriptan is approximately 15% due to significant first-pass metabolism. The elimination half-life is about 2.5 hours. The subcutaneous injection achieves the fastest onset (10-15 minutes) and highest bioavailability. Tablets take 30-60 minutes to begin working. Food has a minimal effect on sumatriptan absorption.
25 mg — tablet
Starting dose for migraine in sensitive patients or those with mild migraines; take at first sign of attack
50 mg — tablet
Most commonly prescribed oral dose; take at first sign of attack; may repeat after 2 hours if needed
100 mg — tablet
Maximum single oral dose; for patients with incomplete response to lower doses; max 200 mg/day
5 mg — nasal spray
Lower dose nasal spray; good for patients sensitive to sumatriptan side effects
10 mg — nasal spray
Mid-range nasal spray dose
20 mg — nasal spray
Standard nasal spray dose; onset 15-30 min; good for nausea patients; max 40 mg/day
4 mg — subcutaneous injection
Lower injection dose; for patients who experience excessive side effects with 6 mg
6 mg — subcutaneous injection
Standard injection dose; fastest onset (10-15 min); used for cluster headaches; max 12 mg/day
Generic sumatriptan tablets are among the most widely available prescription medications in the United States. As of 2026, sumatriptan is not listed on the FDA Drug Shortages database — there is no national shortage. The patent expired in 2008, and multiple manufacturers now produce generic sumatriptan, creating a robust and resilient supply chain that is far more stable than many other prescription drugs.
However, localized pharmacy stock-outs do occur, particularly for brand-name Imitrex (which is produced in lower volumes than generics), the nasal spray formulation, and subcutaneous injection forms. Specialty brands like Tosymra and Zembrace SymTouch are stocked at fewer pharmacies and are more prone to local unavailability. High-volume chain pharmacies (CVS, Walgreens, Walmart) are the most reliably stocked for generic sumatriptan tablets.
When you can't find sumatriptan at your usual pharmacy, medfinder calls pharmacies in your area on your behalf to identify which ones have your specific Imitrex or sumatriptan prescription in stock. Results are texted directly to you — no phone tag required.
Sumatriptan (Imitrex) is a prescription medication but is not a controlled substance, meaning there are no DEA scheduling requirements for prescribers. Any licensed healthcare provider with prescriptive authority can prescribe it. Prescribers do not need special DEA registration or state controlled substance registration beyond their standard license to prescribe sumatriptan.
Common prescriber types for Imitrex include:
Telehealth availability is excellent for sumatriptan. Since it is not a controlled substance, it can be prescribed via a standard telehealth visit without any in-person examination requirement. Many platforms — including Teladoc, MDLive, Cerebral, Sesame, and Nurx — offer same-day or next-day migraine consultations with electronic prescriptions sent directly to your preferred pharmacy.
No. Imitrex (sumatriptan) is not a controlled substance. It has no DEA drug schedule — it is not Schedule II, III, IV, or V. This is an important distinction from many other prescription drugs, particularly those used for pain or neurological conditions.
Because sumatriptan is not a controlled substance, prescribing and dispensing it is straightforward: it can be called in or faxed to pharmacies, prescribed via telehealth without an in-person visit requirement, refilled without special state-specific controlled substance regulations, and is not subject to prescription drug monitoring program (PDMP) restrictions that apply to opioids and other scheduled drugs.
For comparison, lasmiditan (Reyvow) — another acute migraine medication — IS a Schedule V controlled substance. If you are switching from sumatriptan to lasmiditan, be aware of this distinction. Sumatriptan remains the non-controlled standard of care for acute migraine.
Most patients tolerate sumatriptan well. The following side effects are most commonly reported (≥2% of patients in clinical trials):
Note: Using sumatriptan on 10 or more days per month can cause medication overuse headache (rebound headache). If you need sumatriptan more than twice a week, talk to your doctor about preventive migraine therapy.
Know what you need? Skip the search.
Rizatriptan (Maxalt)
Fellow triptan with the fastest oral onset (~20 minutes). Available as tablet and ODT (orally disintegrating tablet). Generic available. Good alternative when sumatriptan is unavailable or has incomplete response.
Zolmitriptan (Zomig)
Triptan available as tablet, ODT, and nasal spray. ODT starts working in ~15 minutes. Good for patients with nausea. Generic tablet available. Also used for cluster headaches.
Eletriptan (Relpax)
Most potent triptan available. Single 40 mg dose often effective for patients with incomplete sumatriptan response. Generic available since 2022.
Ubrogepant (Ubrelvy)
CGRP receptor antagonist gepant. Safe for patients with cardiovascular risk who cannot take triptans. No vasoconstriction. Brand only as of 2026.
Rimegepant (Nurtec ODT)
Uniquely approved for both acute migraine treatment and prevention. CGRP gepant with ODT format. Safe for cardiovascular patients. Brand only as of 2026.
Prefer Imitrex? We can find it.
MAO inhibitors (phenelzine, tranylcypromine, linezolid, isocarboxazid)
majorContraindicated — increases sumatriptan exposure up to 7-fold; risk of serotonin syndrome and hypertensive crisis. Do not take sumatriptan within 14 days of stopping an MAOI.
Ergot-containing drugs (dihydroergotamine, ergotamine)
majorContraindicated within 24 hours — additive vasospasm risk. May cause severely reduced blood flow to extremities or vital organs.
Other triptans (rizatriptan, zolmitriptan, eletriptan, naratriptan, almotriptan, frovatriptan)
majorContraindicated within 24 hours — additive vasospasm and serotonergic effects.
SSRIs (fluoxetine, sertraline, escitalopram, paroxetine, citalopram)
moderateSerotonin syndrome risk — use with caution. Monitor for agitation, hyperthermia, tachycardia, and muscle rigidity.
SNRIs (venlafaxine, duloxetine, desvenlafaxine)
moderateSerotonin syndrome risk — use with caution. Monitor for serotonin syndrome symptoms.
Tricyclic antidepressants (amitriptyline, nortriptyline)
moderateSerotonin syndrome risk — use with caution. Both affect serotonin pathways.
Methylene blue
majorContraindicated — inhibits MAO-A, significantly increases serotonin levels. Avoid combination.
Propranolol
minorMinor pharmacokinetic interaction — propranolol can increase sumatriptan blood levels by ~20%. Generally not clinically significant but monitor for increased side effects.
St. John's Wort
moderateHerbal supplement that increases serotonin levels. Avoid combination with sumatriptan to reduce serotonin syndrome risk.
Imitrex (sumatriptan) has been helping migraine patients for over 30 years, and it remains one of the most effective and affordable acute migraine treatments available in 2026. With multiple generic manufacturers producing it and prices as low as $10.40 per fill with discount coupons, cost and access are both manageable for most patients. Its non-controlled status means getting or renewing a prescription is straightforward — including via telehealth.
The key principles for Imitrex success: take it early (at the first sign of a migraine), don't use it too frequently (no more than 10 days per month to avoid medication overuse headache), and ensure your doctor knows all your other medications (especially SSRIs, SNRIs, and MAOIs) to manage drug interaction risks. If you have cardiovascular risk factors, discuss with your doctor whether triptans are appropriate for you — newer CGRP gepants may be a safer alternative.
If you're having trouble finding Imitrex or generic sumatriptan at your pharmacy, medfinder can help you locate which pharmacies near you have it in stock — saving you the time and frustration of calling around, especially during or before a migraine attack.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
Real-time availability
Medfinder is actively checking pharmacy inventory for Imitrex. We don't publish a number until we have enough verified pharmacy checks to be accurate — start a search and our team confirms current availability near you, usually within 24 hours.
ChatGPT
Claude
Gemini